True. — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Cambiotics develops a precision-formulated probiotic whose bacterial strains interact with PFAS ("forever chemicals") in the gut to support their removal from the body through the digestive system.
BiotechDeep TechWellness & Fitness
Anna Lindell(VP of Technology & Co-founder)Kiran Raosaheb Patil(Co-founder)Peter Holme Jensen(Co-founder)
Co-investorsCollaborative Fund
Shellworks develops VIVOMER, a compostable material made by collaborating with microorganisms that produce natural polymers, designed to perform like plastic but break down without leaving waste.
BiotechCircular EconomyClimate TechNew MaterialsLondon
Insiya Jafferjee(Founder)inAmir Afshar(Founder)inEdward Jones(Director)
BoardFelix Mounier(Director)
Co-investorsBoxGroupEnvestorsFounder CollectiveSie VenturesVersion One VenturesLocalGlobe+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







